Abstract
Despite the relatively high prevalence of thyroid cancer, the occurrence of multiple synchronous, distinct subtypes of primary thyroid carcinoma is uncommon. The incidental finding of papillary thyroid microcarcinoma in a gland with a biologically relevant follicular or medullary carcinoma is more frequent than the synchronous occurrence of multiple clinically significant carcinomas. We report a case of synchronous papillary and follicular thyroid carcinomas metastatic to lymph node and bone, respectively. Next generation sequencing showed BRAF V600E mutation in the primary papillary carcinoma and NRAS Q61R mutation in the primary follicular carcinoma and bony metastasis. To our knowledge, this is the first reported case of synchronous and metastatic primary papillary and follicular carcinomas, and the first report of synchronous BRAF V600E mutated papillary and NRAS mutated follicular carcinoma.
Similar content being viewed by others
References
National Cancer Institute SEER Program Database. Cancer stat facts: thyroid cancer. National Cancer Institute, 2017. https://seer.cancer.gov/statfacts/html/thyro.html. Accessed 20 April, 2017
Rossi S, Fugazzola L, De Pasquale L, Braidotti P, Cirello V, Beck-Peccoz P, Bosari S, Bastagli A. Medullary and papillary carcinoma of the thyroid gland occurring as a collision tumor: report of three cases with molecular analysis and review of the literature. Endocr Relat Cancer 12: 281–289, 2005.
Jain M, Verma D, Thomas S, Chauhan, R. Mixed medullary-papillary carcinoma thyroid: an uncommon variant of thyroid carcinoma. J Lab Physicians 6(2): 133–135, 2014. doi: 10.4103/09742727.141520
Nangue C, Bron L, Portmann L, Volante M, Ris H, Monnier P, Andrejevic-Blant S. Mixed medullary-papillary carcinoma of the thyroid: report of a case and review of the literature. Head and Neck 31(7): 968–974, 2009. doi: 10.1002/hed.20984
Hasney C, Amedee R. Mixed medullary-papillary carcinoma of the thyroid: a case report. Laryngoscope 120(suppl S4): S153, 2010. doi: 10.1002/lary.21617
Verdi D, Pennelli G, Galuppini F, Pelizzo MR, Toniato A. Synchronous papillary and follicular carcinomas in the same thyroid: case report and review of the literature. Updates Surg 65(4): 329–332, 2013. doi: 10.1007/s13304-012-0152-5
Mazeh H, Orlev A, Mizrahi I, Gross D, Freund H. Concurrent medullary, papillary, and follicular thyroid carcinomas and simultaneous Cushing’s syndrome. Eur Thyroid J 4:65–68, 2015. doi:10.1159/000368750
Cupisti K, Raffel A, Ramp U, Wolf A, Donner A, Krausch M, Eisenberger CF, Knoefel WT. Synchronous occurrence of a follicular, papillary, and medullary thyroid carcinoma in a recurrent goiter. Endocr J 52(2): 281–285, 2005.
Ma J, Du, J, Zhang Z, Wang H, Wang J. Synchronous primary triple carcinoma of thyroid and kidney accompanied by solitary fibrous tumor of the kidney: a unique case report. Int J Cain Exp Pathol 7(7): 4268–4273, 2014.
Ganguly R, Mitra S, Datta AK. Synchronous occurrence of anaplastic, follicular, and papillary carcinomas with follicular adenoma in thyroid gland. Indian J Pathol Microbiol 53(2): 337–339, 2010. doi:10.4103/0377-4929.64328
Plauche V, Dewenter T, Walvekar R. Follicular and papillary carcinoma: a thyroid collision tumor. Indian J Otolaryngol Head Neck Surg 65(suppl 1) S182-S184, 2013. doi: 10.1007/s12070-011-0450-0
Lam AK, Lo C, Lam KS. Papillary carcinoma of thyroid a 30-year clinicopathologic review of the histological variants. Endocr Pathol 16(4): 323–330, 2005.
Parameswaran R, Hu JS, En NM, Tan WB, Yuan NK. Patterns of metastasis in follicular thyroid carcinoma and the difference between early and delayed presentation. Ann R Coll Surg Engl 99(2):151–154, 2017. doi: 10.1308/rcsann.2016.0300
Kadri S, Long BC, Mujacic I, Zhen CJ, Wurst MN, Sharma S, McDonald N, Niu N, Benhamed S, Tuteja J, Seiwert T, White KP, McNerney ME, Fitzpatrick C, Wang YL, Furtado LV, Segal JP. Clinical validation of a next generation sequencing genomic oncology panel via cross-platform benchmarking against established amplicon sequencing assays. J Mol Diagn 19(1): 43–56, 2017. doi: 10.1016/j.jmoldx.2016.07.012
Giordano TJ. Follicular cell thyroid neoplasia: insights from genomics and The Cancer Genome Atlas research network. Curr Opin Oncol 28(1): 1–4, 2016. doi: 10.1097/CCO.0000000000000248
Rivera M, Ricarte-Filho J, Patel S, Tuttle M, Shaha A, Shah J, Fagan J, Ghossein R. Encapsulated thyroid tumors of follicular cell origin with high grade features (high mitotic rate/tumor necrosis): a clinicopathologic and molecular study. Hum Pathol 41(2): 172–189, 2010. doi: 10.1016/j.humpath.2009.08.011
Hsaio SJ, Nikiforov YJ. Molecular approaches to thyroid cancer diagnosis. Endocr Relat Cancer 21:T301–T313, 2014. doi: 10.1530/ERC-14-0166
Pilarski R, Burt R, Kohlman W, Pho L, Shannon KM, Swisher E. Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst 105(21): 1607–1616, 2013. doi: 10.1093/jnci/djt277
Cameselle-Teijeiro J, Fachal C, Cabezas-Agricola JM, Alfonsin-Barreiro N, Abdulkader I, Vega-Gliemmo A, Hermo JA. Thyroid pathology findings in Cowden syndrome: a clue for the diagnosis of the PTEN hamartoma tumor syndrome. Am J Clin Pathol 144(2): 322–328, 2015. doi: 10.1309/AJCP84INGJUVTBME
Harach HR, Soubeyran I, Brown A, Bonneau D, Longy M. Thyroid pathologic findings in patients with Cowden disease. Ann Diagn Pathol 3(6): 331–340, 1999.
Lin J. Papillary thyroid carcinoma with lymph node metastases. Growth Factors 25(1): 41–49, 2007. doi: 10.1080/08977190601000095
Madani A, Jozhagi Y, Tabah R, How J, Mitmaker E. Rare metastases of well-differentiated thyroid cancers: a systematic review. Ann Surg Onc 22:460–466, 2015. doi: 10.1245/s10434-014-4058-y
Nixon IJ, Wichter NM, Palmer FL, Tuttle RM, Shaha AR, Shah JP, Patel SG, Ganly I. The impact of distant metastases at presentation on prognosis in patients with differentiated carcinoma of the thyroid gland. Thyroid 22(9): 884–889, 2012. doi: 10.1089/thy.2011.0535
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Ethics Approval
For this type of study, formal consent is not required. This article does not contain any studies with human participants or animals performed by any of the authors.
Informed Consent
Informed consent was obtained from all individual participants in this study.
Rights and permissions
About this article
Cite this article
Cracolici, V., Mujacic, I., Kadri, S. et al. Synchronous and Metastatic Papillary and Follicular Thyroid Carcinomas with Unique Molecular Signatures. Endocr Pathol 29, 9–14 (2018). https://doi.org/10.1007/s12022-017-9491-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12022-017-9491-6